期刊文献+

洛伐他汀对BMSCs成骨分化不同阶段Cbfa1、BMP-2表达的影响 被引量:1

EFFECT OF LOVASTATIN ON EXPRESSION LEVELS OF CBFA1 AND BMP-2 IN BMSCS AT DIFFERENT PHASE OF OSTEOGENIC DIFFERENTIATION
原文传递
导出
摘要 目的研究洛伐他汀促进大鼠骨髓基质干细胞(bone marrow stromal cells,BMSCs)向成骨细胞分化过程中特异性基因Cbfa1、BMP-2 mRNA表达的影响。方法取6周雌性SD大鼠的双侧股骨和胫骨骨髓细胞进行体外成骨诱导培养,于第一次传代后加入浓度为5μmol/L洛伐他汀或等量溶剂培养,分别于细胞培养第十四、二十一、二十八天提取RNA,并采用realtime RT-PCR法于上述时间点检测Cbfa1、BMP-2mRNA的表达,细胞培养至35d,采用茜素红染色观察细胞外基质矿化能力。结果①洛伐他汀可促进成骨诱导分化大鼠BMSCs细胞外基质的矿化能力。②mRNA表达水平:第十四天干预组Cbfa1的表达显著高于对照组,BMP-2的表达水平无显著组间差别;第二十一天干预组Cbfa1、BMP-2的表达均显著高于对照组;第二十八天BMP-2表达显著高于对照组,Cbfa1的表达无组间差别(P<0.05)。结论洛伐他汀可促进大鼠BMSCs向成骨细胞分化,其作用机制可能与在其分化不同阶段调控Cbfa1、BMP-2的表达有关。 Objective To investigate the effect of lovastatin on mRNA expression levels of Cbfal and BMP -2 in bone marrow stromal sells(BMSCs) at different phase of osteogenic differentiation. Methods BMSCs derived from the tibia and femur of 6 weeks old famale SD rats were cultured in vitro in osteoblastic- induced medium since the first subculture and divided into lovastatin stimulated group and control group, treated with 5umol/L lovastatin or vehicle as control repectively. Alizarin red staining was performed at 35th day to assess the mineralization of extracellular matrix. Real time RT - PCR was performed at 14th, 21th, 28th day to evaluate the expression levesls of Cbfal and BMP- 2 separately. Results Lovastatin could promote the extracellular matrix mineralization, mRNA expression: At 14th day, the expression of Cbfal was increased significantly in lovastatin stimulated group compared with control group; at 21th day, both Cbfal and BMP- 2 were significantly higher than those of control group; at 28th day, the expression of BMP- 2 was still markedly higher compared with control group. Conclusion Lovastatin can promote the osteogenic differentiation of BMSCs, regulate the mRNA expression levels of Cbfal and BMP- 2 at the different phase of osteogenic differentiation, and it may be participate in this progress.
出处 《中国煤炭工业医学杂志》 2014年第5期779-781,共3页 Chinese Journal of Coal Industry Medicine
基金 唐山市科技计划项目(项目编号:12130236b)
  • 相关文献

参考文献10

  • 1Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins[J]. Science, 1999,286(5446) : 1946 - 1949.
  • 2Garrett IR, Gutierrez G, Mundy GR. Statins and bone formation[J]. Curr Pharm Des,2001,7(8):715 - 736.
  • 3Yao W, Farmer R, Cooper R, et al. Simvastatin did not prevent nor restore ovarieetomy- induced bone loss in adult rats[J]. J Museuloskelet Neuronal In teract,2006,6(3) :277 - 283.
  • 4Chou J, Ito T, Bishop D, et al. Controlled Release of Simvastatin from Biomimetic β - TCP Drug Delivery System[J]. PLoS One, 2013,8 ( 1 ) : e54676.
  • 5Qi Y, Zhao T, Yan W, et al. Mesenchymal stem cell sheet transplantation combined with locally released simvastatin enhances bone formation in a rat tibia os- teotomy model[J]. Cytotherapy,2013,15(1) 144 - 56.
  • 6Li X,Cui Q, Kao C, et al. Lovastatin inhibits adipo- genic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/ Runx2 expression in bone marrow mesenchymal cell cultures[J]. Bone,2003,33(4):652- 659.
  • 7Lee JS, Thomas DM, Gutierrez G, et al. HES1 coop- erates with pRb to activate RUNX2 - dependent transcription[J]. J Bone Miner Res, 2006,21 (6): 921 - 933.
  • 8Smith N1, Dong Y, Lian JB, et al. Overlapping expression of Runxl (Cbfa2) and Runx2 (Cbfal) transcription factors supports cooperative induction of skeletal development[J]. J Cell Physiol,2005,203 (1):133 - 143.
  • 9Yoshida CA,Yamamoto H,Fujita T,et al. Runx2 and Runx3 are essential for chondrocyte maturation and Runx2 regulates limb growth through induction of Indian hedgehog[J]. Genes, 2004,18: 952 - 963.
  • 10郭启,张柳.骨形态发生蛋白-2在骨修复中的作用研究进展[J].中国煤炭工业医学杂志,2007,10(5):494-496. 被引量:3

二级参考文献32

  • 1张民,卢汉生,杜靖远.骨形态发生蛋白复合同种松质骨载体修复节段性骨缺损的实验研究[J].实用骨科杂志,2004,10(3):219-221. 被引量:3
  • 2胡蕴玉.骨诱导及BMP的研究现状与展望[J].中华外科杂志,1996,34(10):579-581. 被引量:24
  • 3Mundy GR,Boyce B,Hughes D,et al.The effects of cytokines and growth factors on osteoblastic cells[J].Bone,1995,17:71 -75
  • 4Urist MR.Bone formation by autointroduction[J].Science,1965,150:893
  • 5Riley EA,Lane JM,Urist MR,et al.Bone morphogenetic protein-2:biology and application[J].Clinic Orthop,1996,324:39
  • 6Wang EA,Rosen V,Cordes P,et al.Purification and characterization of other distinct bone-inducing factors[J].Proc Natl Acad Sci USA,1990,85:9484
  • 7Hofbauer LC,Hofbauer AE.Taking the message to the nucleus:MAD protein as a mediator of bone morphogenetic protein singling[J].Eur J Endocrinol,1996,185:654
  • 8Hoodless PA,Haerry T,Abdollah S,et al.A MAD-related protein that functions in BMP-2 signaling pathways[J].Cell,1995,85:489
  • 9Kaffagiri T,Yamaguch A.Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblast into the osteoblast lineage[J].J Cell Biol,1994,127:1755
  • 10Valentin-Opran A.Clinical evaluation of recombinant human bone morphogenetic protein-2[J].Clinical Orthopaedics & Related Research,2002,395:110-120

共引文献2

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部